线粒体向改善了NMIBC治疗中单片氧可切割前药的选择性
Kazi Md Mahabubur Rahman1, Ganesh Bist1, Soniya Kumbham1
1Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York, USA.
Photochemistry and photobiology
|March 3, 2024
概括
针对线粒体的前体药物通过将化疗药物集中在癌细胞内来增强癌症治疗. 这种方法提高了疗效,并减少了对健康组织的毒性.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 线粒体在癌症治疗中至关重要,因为它通过信号传递亡.
- 赫西氨基氨酸诱导癌细胞线粒体中的原氨酸IX (PpIX).
- 在照明时,PpIX可以从前药物中释放化疗药物.
研究的目的:
- 合成和评估针对线粒体的预药物,以加强癌症治疗.
- 通过向癌细胞线粒体来提高化疗的选择性.
- 为了减少非癌症组织的非目标毒性.
主要方法:
- 使用罗达胺部分合成针对线粒体的前体药物.
- 在实验室中评估癌症与上皮细胞中的细胞吸收.
- 在体内评估前药物扩散在一个正位素鼠膀瘤模型.
主要成果:
- 针对线粒体的前体药物在癌细胞中表现出优越的吸收.
- 细胞内度在RT112癌细胞和BdEC细胞中高出2-3倍.
- 在体内,前药物扩散在瘤区域高达34倍,相比于非瘤膀区域.
结论:
- 对线粒体的向增强了癌细胞和瘤中前药物的积累.
- 这一策略提高了光动力学治疗的有效性,并减少了非特异性毒性.
- 线粒体类产药为选择性癌症治疗提供了一个有前途的方法.
关键词:
哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈哈在 NMIBC 中,NMIBC 是一个非常重要的机构.在PpIX-PDT中使用.阴离子前药物 阴离子前药物针对线粒体的向.更多相关视频
相关概念视频
Electron Transport Chain: Complex I and II
13.3K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
13.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Translocation of Proteins into the Mitochondria
3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
Mitochondrial Precursor Proteins
2.6K
Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70 chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial...
Most of the mitochondrial...
2.6K


